Close Menu

NEW YORK – NeoGenomics announced Tuesday a strategic collaboration with liquid biopsy firm Inivata for the commercialization of Inivata's InVisionFirst-Lung test in the US.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.